Immunosuppressive therapy with tacrolimus is a potential drug candidate for the prevention of unexplained or preeclamptic stillbirths with Th1-dominant immune states: a case series of five patients.

Hisano, Michi; Nakagawa, Koji; Suzuki, Tomo; Sugiyama, Rikikazu; Yamaguchi, Koushi

Hisano, Michi; Nakagawa, Koji; Suzuki, Tomo; Sugiyama, Rikikazu; Yamaguchi, Koushi.

Afiliación

Hisano M; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Nakagawa K; Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan.
Suzuki T; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Sugiyama R; Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan.
Yamaguchi K; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

J Matern Fetal Neonatal Med ; 36(2): 2258254, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37705258

Asunto(s)

Aborto Espontáneo; Síndrome HELLP; Preeclampsia; Humanos; Femenino; Embarazo; Tacrolimus/uso terapéutico; Mortinato; Preeclampsia/tratamiento farmacológico; Preeclampsia/prevención & control; Preparaciones Farmacéuticas; Cesárea; Terapia de Inmunosupresión; Inmunosupresores/uso terapéutico; Síndrome HELLP/tratamiento farmacológico; Síndrome HELLP/prevención & control

Palabras clave

Tacrolimus; maternal-fetal immune abnormality; preeclampsia; stillbirth

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preeclampsia / Aborto Espontáneo / Síndrome HELLP Límite: Female / Humans / Pregnancy Idioma: En Revista: J Matern Fetal Neonatal Med Asunto de la revista: OBSTETRICIA / PERINATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google